- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT05296343
Guidelines for Parental Involvement in the Care of Suicidal Youth (S-Urg-Quali)
Developing Guidelines for Parental Involvement in the Emergency Care of Suicidal Adolescents and Young Adults: a Qualitative Study
Parents occupy a central place in the emergency care of suicidal adolescents and young adults. However, from 15 to 25yo, three different administrative situations exist in France:
- <16yo: admission to a child ED by a team trained to receive the youngest patients.
- 16-18yo: admission to an adult ED by team devoted to adult care, no exit without parents' authorization.
- >18yo: admission to an adult ED by team.
Laying on qualitative observational protocol and a Delphi approach, this study will explore the perspective of adolescents and young adults following a suicidal attempt, the perspective of their parents, and the perspective of their healthcare professionals to build guidelines for parental involvement in care of suicidal youths.
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
Suicide is the second leading cause of death among 15-25 year olds, with the highest rate of hospitalization for SC of any age group. The psychopathology of suicidal behavior in adolescents and young adults (AYA) is homogeneous: risk factors, precipitating factors, representations. Parents occupy a central place in care. They are i) involved in the care decision; ii) actively involved in care; and ii) a source of motivation for trust and adherence to care.
However, if the psychopathology of suicidal crisis is homogeneous, the transition between pediatric and adult care implies very different management in the emergency department (ED). In France, three situations can be described:
- <16yo: admission to a child ED by a team trained to receive the youngest patients.
- 16-18yo: admission to an adult ED by team devoted to adult care, no exit without parents' authorization.
- >18yo: admission to an adult ED by team devoted to adult care, no right to contact the parents in case of patient opposition.
- Before 16 years of age: admission to the children's UAS, care by a team trained to receive the youngest patients.
- 16-18 years: admission to the adult UAS, care by adult professionals, clinical and legal particularities of care for minors.
- After 18 years old: admission to adult UAS, legal constraints of the adult care setting.
The objectives of this qualitative observational study is to build guidelines for the involvement of the parents in the care in these three situations.
The study will include adolescents and young adults from the three situations, their parents and the professionals who take care of them. Individual semi-structured interviews will be organized to collect their experiences. Qualitative analyses will be conduct, following Interpretative Phenomenological Analysis. A pre-approved guideline will be construct and a Delphi approach will be conducted to approved the final version of the guideline.
Studientyp
Einschreibung (Voraussichtlich)
Kontakte und Standorte
Studienorte
-
-
-
Clermont-Ferrand, Frankreich, 63000
- CHU de Clermont-Ferrand
-
Hauptermittler:
- Jonathan Lachal
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
Adolescents and Young adults
- Admitted to an Emergency Department (ED) following a suicidal act or considered as such by the medical team
Parents
- Parents of the included youths >18y
Healthcare professionals
- >18y
- Working in ED
- Usually taking care of suicidal youths
All the participants
- French speaking
- Affiliation to a social security regime
- Participation agreement
Exclusion Criteria:
All the participants
- Present an acute somatic or psychiatric disease which may hinder the well organization of the interview
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
|---|
|
Adolescents and young adults
Boys and girls from 15 to 25 years old admitted to an Emergency Department (ED) following a suicidal act or considered as such by the medical team
|
|
Parents
One or the two parents of the included adolescents and young adults
|
|
Healthcare professionals
Professionals working in one emergency departments of the inclusion centers and who usually take care of suicidal adolescents and young adults
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Developing guidelines defining the role of parents in the medical decision and the care of the youths
Zeitfenster: Day 1
|
Thematic framework summarizing the perspectives of three groups of participants.
|
Day 1
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Describing each context of care
Zeitfenster: Day 1
|
Qualitative description of each of the three context of care (<16y, 16-18y, >18y)
|
Day 1
|
|
Describing expectations from each group
Zeitfenster: Day 1
|
Qualitative description of each of the three participant groups (adolescents and young adults, parents, professionals)
|
Day 1
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Jonathan Lachal, University Hospital, Clermont-Ferrand
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Voraussichtlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- AOI 2021 LACHAL
- 2021-A03244-37 (Andere Kennung: ANSM)
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .